From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Life365 Engages Objective Capital Partners to Assist in Coordinating Strategic Capital and Partnership Opportunities
Life365, a leader in intelligent digital health infrastructure development and solution delivery, today announced that it has engaged Objective Capital Partners, LLC, to serve as a financial advisor to assist the Company in coordinating strategic capital and partnerships with the goal of maximizing the value of the strong intellectual property portfolio and digital health platform. The […]
New Study on Children With Autism and Developmental Delays Show TouchPoints Wearable Devices Reduced 72% of Disruptive and Self-Harming Behaviors
Data released from Ysgol Maes Y Coed, a special educational needs school in South Wales, UK showed a staggering reduction in problematic behaviors in case studies of children ages 7-14. Researchers tracked baseline behaviors for one week without TouchPoints, stress-relieving neuroscience wearables, and one week with the devices on the children during the entire school day.
The HonorHealth vice president of research and a retired executive at W.L. Gore & Associates, Inc. have assumed new leadership roles with a statewide committee charged with advancing the biosciences in Arizona.
As the second leading cause of death worldwide, cancer is a focal point in both clinical research and health care fields, but not all cancers are created equal. While some cancers are now much less deadly due to recent medical advances, other aggressive cancers remain highly resistant to currently available therapies.
- Open Door at the ASU Biodesign Institute - Inspiring for All Ages
- Venture Madness 2019
- 02/27/2019 - 02/28/2019
- BIO5 Open House
- Concussions 2019
- MDMA 2019 FDA Forum
- 03/14/2019 - 03/15/2019
- Palo Alto